American Association of Individual Investors17 小时
Which Is a Better Investment, Blueprint Medicines Corporation or Zai Lab Limited Stock?
Learn more about whether Blueprint Medicines Corporation or Zai Lab Limited is a better investment based on AAII's A+ ...
Investing2 天
Nuvation Bio launches EAP for lung cancer drug taletrectinib
The program targets individuals with locally advanced or metastatic ROS1-positive non-small cell lung cancer (NSCLC) who have exhausted other treatment options. The EAP, authorized by the U.S ...
pharmaphorum1 天
FDA widens label for BMS’ cancer drug Augtyro
Augtyro (repotrectinib), which first got a green light from the FDA as a treatment for ROS1-positive non-small ... with other therapies for NTRK gene fusion cancers, including Rozlytrek ...
pharmaphorum3 天
Relief for Lilly as drug from $8bn Loxo deal clears pivotal trial
The study “continues to confirm that RET fusions are clinically targetable alterations, placing them in the company of activating EGFR/ALK/ROS1 alterations,” said Drilon. “We are encouraged ...